ZFIN ID: ZDB-FISH-210902-5
Fish name: tp53zdf1/zdf1; nn1002Tg; nn1003Tg (AB)
Genotype: tp53zdf1/zdf1; nn1002Tg; nn1003Tg (AB)
Targeting Reagent: none
HUMAN DISEASE MODELED by tp53zdf1/zdf1; nn1002Tg; nn1003Tg (AB)
No data available
GENE EXPRESSION
Gene expression in tp53zdf1/zdf1; nn1002Tg; nn1003Tg (AB)
RNA expression
Expressed Gene Structure Conditions Figures
asgrl1 chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 9 with image from Wu et al., 2020
ccne1 chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
cdk1 chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
cdk2 chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
col1a1a chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
ccn2a chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
ddah1 chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 9 with image from Wu et al., 2020
hnf4a chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 9 with image from Wu et al., 2020
hpse chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
hsd11b1lb chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 9 with image from Wu et al., 2020
tdo2a chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 9 with image from Wu et al., 2020
Protein expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in tp53zdf1/zdf1; nn1002Tg; nn1003Tg (AB)
Phenotype Conditions Figures
hepatocyte apoptotic, abnormal increased food availability, particle radiation Figure 4 with image from Wu et al., 2020
hepatocyte apoptotic, ameliorated chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 4 with image from Wu et al., 2020
hepatocyte morphology, abnormal increased food availability, particle radiation Figure 5 with image from Wu et al., 2020
hepatocyte morphology, ameliorated chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 5 with image from Wu et al., 2020
hepatocyte apoptotic process increased occurrence, abnormal increased food availability, particle radiation Figure 4 with image from Wu et al., 2020
hepatocyte apoptotic process occurrence, ameliorated chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 4 with image from Wu et al., 2020
liver cdk1 expression amount, ameliorated chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
liver ccne1 expression amount, ameliorated chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
liver hpse expression amount, ameliorated chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
liver hsd11b1lb expression amount, ameliorated chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 9 with image from Wu et al., 2020
liver ccn2a expression amount, ameliorated chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
liver col1a1a expression amount, ameliorated chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
liver cdk2 expression amount, ameliorated chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
liver hnf4a expression increased amount, abnormal chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 9 with image from Wu et al., 2020
liver tdo2a expression increased amount, abnormal chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 9 with image from Wu et al., 2020
liver ccne1 expression increased amount, abnormal increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
liver cdk1 expression increased amount, abnormal increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
liver cdk2 expression increased amount, abnormal increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
liver hpse expression increased amount, abnormal increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
liver ddah1 expression increased amount, abnormal chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 9 with image from Wu et al., 2020
liver col1a1a expression increased amount, abnormal increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
liver asgrl1 expression increased amount, abnormal chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 9 with image from Wu et al., 2020
liver ccn2a expression increased amount, abnormal increased food availability, particle radiation Figure 3 with image from Wu et al., 2020
liver hepatocellular carcinoma amount, ameliorated increased food availability, particle radiation Figure 5 with image from Wu et al., 2020
liver hepatocyte proliferation normal occurrence, normal increased food availability, particle radiation Figure 5 with image from Wu et al., 2020
liver hepatocyte proliferation normal occurrence, normal chemical treatment by gavage: fucoidan, increased food availability, particle radiation Figure 5 with image from Wu et al., 2020

CITATIONS  (1)